This inventor holds 2 USPTO granted patents. Top assignees: Modelisation Et Mise Au Point De Molecules Medicinales, Paris Sciences Et Lettres-Quartier Latin. Active years: 1999-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- L'Hay-les-Roses, FR (1999)
- Cachan, FR (2017)
Company Filing History:
Years Active: 1999-2017
Title: Gerard Jaouen: Innovator in Anticancer Compounds
Introduction
Gerard Jaouen is a notable inventor based in Cachan, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anticancer properties. With a total of 2 patents, his work has the potential to impact cancer treatment significantly.
Latest Patents
Jaouen's latest patents include innovative compounds designed to combat cancer. One of his notable inventions is related to metallocene derivatives with anticancer activity. This invention pertains to a compound of a specific formula or its pharmaceutically acceptable salt or solvate, which can be utilized in cancer treatment. Another patent focuses on diarylethylene metallocene derivatives and their preparation processes. These compounds are particularly useful in treating estrogen-dependent cancers, showcasing their potential anti-tumor activity.
Career Highlights
Throughout his career, Jaouen has worked with various organizations, including Modelisation Et Mise Au Point De Molecules Medicinales and Paris Sciences Et Lettres-Quartier Latin. His experience in these institutions has allowed him to refine his expertise in medicinal chemistry and contribute to groundbreaking research.
Collaborations
Jaouen has collaborated with notable colleagues such as Siden Top and Pascal Pigeon. These partnerships have likely enhanced his research and development efforts in the field of anticancer compounds.
Conclusion
Gerard Jaouen's innovative work in the development of anticancer compounds positions him as a significant figure in medicinal chemistry. His patents reflect a commitment to advancing cancer treatment through scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile